As a publicly traded organization, AngioSoma, Inc. is an SEC reporting company, which requires the company to follow the mandates of Regulation Fair Disclosure (also known as “Regulation FD” or “Reg FD“). Regulation FD requires public companies to “disclosure material information to all investors at the same time.”
To that extent, AngioSoma, Inc. provides all material information through press releases and Form 8K submissions to the SEC. AngioSoma, Inc. only Tweets non material information, or references to SEC mandated filings. Search for our ticker symbol $SOAN to see all information on our stock.
AngioSoma, Inc. files its 10Q for the period ending June 30, 2016 (see SEC’s website at https://t.co/l3udkPKPXj).
— Administrator (@angiosoma_admin) September 13, 2016
© 2016 by AngioSoma, Inc., all rights reserved.